| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Maura Calvani | Q89861235 |
| Marina Vignoli | Q89861239 | ||
| Claudio Favre | Q90415101 | ||
| Angela Subbiani | Q92619510 | ||
| P2860 | cites work | 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities | Q22254609 |
| Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1 | Q24291189 | ||
| Molecular characterization of the human beta 3-adrenergic receptor | Q24320014 | ||
| Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger | Q24559960 | ||
| Role of oxidative stress in female reproduction | Q24814956 | ||
| Role of ROS and RNS Sources in Physiological and Pathological Conditions | Q26740342 | ||
| Natural compounds as modulators of NADPH oxidases | Q26829513 | ||
| Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement | Q26861119 | ||
| Neuroendocrine regulation of inflammation | Q27001639 | ||
| Oxidative stress: a concept in redox biology and medicine | Q27022650 | ||
| MYC activation is a hallmark of cancer initiation and maintenance | Q27026026 | ||
| Free radicals in the physiological control of cell function | Q27860480 | ||
| Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide. | Q38141474 | ||
| Transcriptional regulation by hypoxia inducible factors | Q38149945 | ||
| Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system. | Q38293740 | ||
| Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs | Q38336991 | ||
| The Oxidative Burst and Related Phenomena in Mouse Macrophages Elicited by Different Sterile Inflammatory Stimuli | Q38354646 | ||
| Noradrenaline increases intracellular glutathione in human astrocytoma U-251 MG cells by inducing glutamate-cysteine ligase protein via β3-adrenoceptor stimulation. | Q38807089 | ||
| Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer | Q38816633 | ||
| Isoprenaline induces epithelial-mesenchymal transition in gastric cancer cells | Q38845440 | ||
| The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo | Q38865724 | ||
| Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade. | Q38974127 | ||
| A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment | Q39065038 | ||
| Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. | Q39138848 | ||
| Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression | Q39158369 | ||
| β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines | Q39210673 | ||
| Correlation between Oxidative Stress, Nutrition, and Cancer Initiation. | Q39438812 | ||
| miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response | Q39439864 | ||
| β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1. | Q39710069 | ||
| Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells | Q39741684 | ||
| Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. | Q39804939 | ||
| Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells | Q39907940 | ||
| Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation | Q40160207 | ||
| Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin. | Q40202144 | ||
| Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma | Q40252227 | ||
| A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle | Q40344303 | ||
| Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. | Q40389863 | ||
| Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells | Q40515501 | ||
| CD95-tyrosine nitration inhibits hyperosmotic and CD95 ligand-induced CD95 activation in rat hepatocytes | Q40606705 | ||
| A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis | Q40660993 | ||
| Nitrosylation of cytochrome c during apoptosis | Q40662665 | ||
| Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway | Q40919226 | ||
| DNA damage by nitric oxide | Q41129364 | ||
| Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium | Q41250498 | ||
| Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells | Q41710686 | ||
| Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells | Q41740990 | ||
| Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells | Q41918423 | ||
| Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas | Q42326772 | ||
| Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression | Q42434242 | ||
| β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling | Q42455230 | ||
| Hypertension in mice lacking the gene for endothelial nitric oxide synthase | Q42478091 | ||
| Comparison of the lipolytic effects of norepinephrine and BRL 37344 in rat brown and white adipocytes | Q42487958 | ||
| Beta3-adrenoceptors in urinary bladder | Q42514928 | ||
| The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide | Q42849616 | ||
| The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome | Q43164200 | ||
| Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase | Q43568413 | ||
| Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice | Q43618843 | ||
| Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels | Q44601105 | ||
| Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines | Q44630367 | ||
| Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
| Superoxide activates mitochondrial uncoupling proteins | Q28214829 | ||
| Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | Q28242612 | ||
| Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling | Q28252897 | ||
| Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis | Q28290519 | ||
| Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1 | Q28296135 | ||
| Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis | Q28363910 | ||
| Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species | Q28484609 | ||
| betaAR signaling required for diet-induced thermogenesis and obesity resistance | Q28508047 | ||
| Nitric oxide synthase modulates angiogenesis in response to tissue ischemia | Q28508302 | ||
| Modulation of oxidative stress as an anticancer strategy | Q29615707 | ||
| The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen | Q29616357 | ||
| Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? | Q29616804 | ||
| Nitric oxide and the immune response | Q29617591 | ||
| Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension | Q30080036 | ||
| Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles | Q31845736 | ||
| Down-regulation of catalase gene expression in the doxorubicin-resistant AML subline AML-2/DX100. | Q31939334 | ||
| Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin | Q32129593 | ||
| The beta3-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism. | Q33178125 | ||
| Effect of oxidative stress on male reproduction | Q33632135 | ||
| NADPH oxidases: a perspective on reactive oxygen species production in tumor biology | Q33632660 | ||
| Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? | Q33643464 | ||
| Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. | Q33649852 | ||
| Nitric oxide-an endothelial cell survival factor. | Q33771670 | ||
| Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. | Q33772458 | ||
| Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy | Q33807824 | ||
| Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis | Q33815723 | ||
| Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. | Q33950554 | ||
| The sympathetic nervous system induces a metastatic switch in primary breast cancer | Q34134468 | ||
| Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells | Q34283019 | ||
| NRF2 and cancer: the good, the bad and the importance of context. | Q34289003 | ||
| Glutathione metabolism and its implications for health | Q34301684 | ||
| Roles of nitric oxide in tumor growth | Q34328781 | ||
| The regulatory role of nitric oxide in apoptosis | Q34342616 | ||
| Free radicals, antioxidants in disease and health | Q34344766 | ||
| Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation | Q36920831 | ||
| Role of nitric oxide in inflammatory diseases | Q37072461 | ||
| Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression | Q37120838 | ||
| beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility | Q37267545 | ||
| The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. | Q37385274 | ||
| Reactive oxygen species in cancer | Q37431048 | ||
| Nitric oxide: an endogenous modulator of leukocyte adhesion | Q37519420 | ||
| Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation | Q37565625 | ||
| Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer | Q37701617 | ||
| Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. | Q37798966 | ||
| The cytoprotective role of the Keap1-Nrf2 pathway | Q37848718 | ||
| Uncoupling proteins and the control of mitochondrial reactive oxygen species production | Q37901603 | ||
| Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids | Q37971269 | ||
| The yin and yang of nitric oxide in cancer progression. | Q38077081 | ||
| Selective β₃-adrenoceptor agonists for the treatment of overactive bladder | Q38086305 | ||
| There's NO binding like NOS binding: protein-protein interactions in NO/cGMP signaling | Q34433389 | ||
| Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer | Q34490726 | ||
| Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism | Q34534013 | ||
| Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors | Q34803030 | ||
| DNA deaminating ability and genotoxicity of nitric oxide and its progenitors | Q34983829 | ||
| Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase | Q35026148 | ||
| Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines | Q35051882 | ||
| Inducible nitric oxide synthase and control of intracellular bacterial pathogens | Q35145721 | ||
| Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro | Q35769839 | ||
| Structure and function of beta3-adrenergic receptors | Q35788108 | ||
| A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer | Q35829723 | ||
| Arg375 tunes tetrahydrobiopterin functions and modulates catalysis by inducible nitric oxide synthase | Q35836392 | ||
| Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancer | Q35872317 | ||
| Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. | Q35877948 | ||
| Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release | Q35981563 | ||
| S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. | Q36017535 | ||
| Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways | Q36089228 | ||
| Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis | Q36089796 | ||
| Molecular mechanisms of beta2-adrenergic receptor function and regulation | Q36305301 | ||
| Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation | Q36357733 | ||
| Defective lung vascular development in endothelial nitric oxide synthase-deficient mice | Q36357774 | ||
| Association of mitochondrial nitric oxide synthase activity with respiratory chain complex I. | Q36397868 | ||
| Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. | Q36522434 | ||
| Role of reactive nitrogen species in male infertility. | Q36571951 | ||
| Redox control of leukemia: from molecular mechanisms to therapeutic opportunities | Q36646486 | ||
| Role of nitric oxide synthesis in macrophage antimicrobial activity | Q36656920 | ||
| Nitric oxide and mitochondria | Q36664501 | ||
| Elevated blood pressures in mice lacking endothelial nitric oxide synthase. | Q36689446 | ||
| Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors | Q36784801 | ||
| Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma | Q36808787 | ||
| Mechanisms for oxidative stress in diabetic cardiovascular disease | Q36824967 | ||
| Nitric oxide and cancer: a review | Q36893209 | ||
| Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade | Q36908901 | ||
| Beta-adrenergic receptor regulation of growth factor protein levels in human choroidal endothelial cells | Q44635814 | ||
| Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative | Q45066268 | ||
| Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase | Q45091743 | ||
| Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation | Q45204892 | ||
| Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection | Q45871900 | ||
| Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy. | Q45941407 | ||
| Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPARγ activation | Q46333857 | ||
| Focusing at the double-edged sword of redox imbalance: signals for cell survival or for cell death? | Q46918302 | ||
| Antimutagenic role of base-excision repair enzymes upon free radical-induced DNA damage | Q47798756 | ||
| Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization. | Q47880195 | ||
| Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. | Q50442563 | ||
| Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. | Q50901208 | ||
| Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. | Q52206621 | ||
| Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells. | Q52568380 | ||
| Redox control in cancer development and progression. | Q52675830 | ||
| The multifaceted roles of nitric oxide in cancer. | Q53433015 | ||
| High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines | Q54281795 | ||
| Identification of critical amino acid residues for human iNOS functional activity. | Q54422842 | ||
| Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells | Q58816342 | ||
| 3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells | Q59809214 | ||
| β-Adrenergic receptor expression in vascular tumors | Q60152692 | ||
| Inactivation of a Peroxiredoxin by Hydrogen Peroxide Is Critical for Thioredoxin-Mediated Repair of Oxidized Proteins and Cell Survival | Q60492244 | ||
| Upregulation of β 3 -Adrenergic Receptor mRNA in Human Colon Cancer: A Preliminary Study | Q60780712 | ||
| β3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival. | Q64974639 | ||
| Endothelium-derived relaxant factor inhibits platelet activation | Q69819466 | ||
| Islet cell DNA is a target of inflammatory attack by nitric oxide | Q70558977 | ||
| A study of the nutritional status of pediatric cancer patients | Q71025128 | ||
| Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase | Q71694221 | ||
| Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases | Q72462338 | ||
| A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation | Q73626811 | ||
| Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition | Q73643152 | ||
| Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression | Q74093447 | ||
| Regulation of the catalase gene promoter by Sp1, CCAAT-recognizing factors, and a WT1/Egr-related factor in hydrogen peroxide-resistant HP100 cells | Q74292788 | ||
| Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death | Q74638430 | ||
| Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression | Q81357415 | ||
| Nitric oxide attenuates vascular endothelial cadherin-mediated vascular integrity in human chronic inflammation | Q82746965 | ||
| Effects of adrenaline in human colon adenocarcinoma HT-29 cells | Q84084243 | ||
| Anti-inflammatory and anti-tumor activity of the marine mangrove Rhizophora apiculata | Q84576594 | ||
| β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma | Q92382579 | ||
| β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation | Q93064595 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | neoplasm | Q1216998 |
| P304 | page(s) | 6346529 | |
| P577 | publication date | 2019-12-14 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells | |
| P478 | volume | 2019 |
Search more.